Medicamen Biotech Ltd.
BSE: 531146 | Sector: Health care |
NSE: MEDICAMEQ | ISIN Code: INE646B01010 |
BSE 15:49 | 03 Feb | 708.20 |
-25.60 (-3.49%) |
OPEN
736.20 |
HIGH
740.95 |
LOW
707.25 |
NSE 15:49 | 03 Feb | 712.95 |
-23.20 (-3.15%) |
OPEN
738.05 |
HIGH
745.85 |
LOW
706.60 |
OPEN | 736.20 |
PREVIOUS CLOSE | 733.80 |
VOLUME | 516 |
52-Week high | 1219.00 |
52-Week low | 558.80 |
P/E | 65.27 |
Mkt Cap.(Rs cr) | 896 |
Buy Price | 710.35 |
Buy Qty | 1.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Medicamen Biotech Ltd. (MEDICAMEQ) - Half Yearly Result
Particulars (![]() |
Sep '22 | Mar '22 | Sep '21 | Mar '21 | Sep '20 |
Net Sales/Income From Operations | 66.62 | 55.39 | 60.05 | 53.26 | 56.89 |
Other Income | 1.49 | 1.17 | 0.56 | 0.54 | 0.22 |
Total Income | 68.11 | 56.56 | 60.61 | 53.80 | 57.10 |
Total Expenditure | 55.11 | 44.11 | 47.78 | 43.12 | 47.44 |
Operating Profit | 13.00 | 12.45 | 12.82 | 10.67 | 9.66 |
Interest | 1.38 | 1.06 | 0.34 | 0.45 | 0.62 |
Gross Profit | 11.62 | 11.40 | 12.48 | 10.23 | 9.04 |
Depreciation | 3.14 | 3.09 | 2.68 | 1.13 | 1.39 |
PBT | 8.48 | 8.30 | 9.80 | 9.10 | 7.65 |
Tax | 1.84 | 2.09 | 1.89 | 1.86 | 2.28 |
Net Profit/(Loss) | 7.20 | 6.53 | 8.37 | 7.16 | 5.33 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 7.20 | 6.53 | 8.37 | 7.16 | 5.33 |
Equity Share Capital | 12.65 | 12.22 | 12.22 | 12.22 | 12.22 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 5.69 | 5.35 | 6.85 | 5.86 | 4.36 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Medicamen Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices